Novel E6 and E7 oncogenes variants of human papillomavirus type 31 in Brazilian women with abnormal cervical cytology

Infection, Genetics and Evolution

Volumn 16, Issue , 2013, Pages 13-18

  Chagas, Bárbara Simas ^a   Batista, Marcus Vinicius de Aragão ^a   Crovella, Sergio ^a,b   Gurgel, Ana Pavla Almeida Diniz ^a   Silva Neto, Jacinto da Costa ^a   Serra, Ivi Gonçalves Soares Santos ^c   Amaral, Carolina Maria Medeiros ^a   Balbino, Valdir Queiroz ^a   Muniz, Maria Tereza Cartaxo ^d   Freitas, Antonio Carlos ^a  

^a FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^b INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

^c Center of Integrated Medicine in Sergipe   (Brazil)

^d FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

Author keywords

Cervical cancer; E6 oncogene; E7 oncogene; Genomic diversity; Human papillomavirus variants

Indexed keywords

EPITOPE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ABNORMAL LABORATORY RESULT; ADULT; AMINO ACID SEQUENCE; ANTIGEN BINDING; ARTICLE; BRAZIL; BRAZILIAN; CANCER GROWTH; CLINICAL FEATURE; DISEASE ASSOCIATION; EPIDEMIOLOGICAL DATA; ETHNIC DIFFERENCE; ETHNIC GROUP; FEMALE; GENE AMPLIFICATION; GENE CLUSTER; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC LINE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GEOGRAPHIC DISTRIBUTION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALIGNANT TRANSFORMATION; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE E6; ONCOGENE E7; PHYLOGENY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE ALIGNMENT; STRUCTURE ANALYSIS; T LYMPHOCYTE; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VIRUS EXAMINATION; VIRUS ISOLATION; VIRUS ONCOGENE;

ADOLESCENT; ADULT; BRAZIL; FEMALE; GENETIC VARIATION; HUMAN PAPILLOMAVIRUS 31; HUMANS; MIDDLE AGED; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS E7 PROTEINS; PAPILLOMAVIRUS INFECTIONS; PHYLOGENY; UTERINE CERVICAL NEOPLASMS;

EID: 84875277115     PISSN: 15671348     EISSN: 15677257     Source Type: Journal    
DOI: 10.1016/j.meegid.2013.02.001     Document Type: Article

References (49)

1. Altschul S.F., Gish W., Miller W., Myers E.W., Lipman D.J. Basic local alignment search tool. J. Mol. Biol. 1990, 215:403-410.
2. Asadurian Y., Kurilin H., Lichtig H., Jackman A., Gonen P., Tommasino M., Zehbe I., Sherman L. Activities of human papillomavirus 16 E6 natural variants in human keratinocytes. J. Med. Virol. 2007, 79:1751-1760.
3. Baldez da Silva M.F., Chagas B.S., Guimarães V., Katz L.M., Feliz P.M., Miranda P.M., Lima A.A., Arraes L.C., Martins D.B., Lima Filho J.L., Stocco R.C., Crovella S., Freitas A.C., Beçak W. HPV31 and HPV33 incidence in cervical samples from women in recife. Braz. Genet. Mol. Res. 2009, 8:1437-1443.
4. Baldez da Silva M.F.P.T., Guimarães V., Silva M.A.R., Amaral C.M.M., Beçak W., Stocco R.C., Freitas A.C., Crovella S. Frequency of human papillomavirus types 16, 18, 31, and 33 and sites of cervical lesions in gynecological patients from recife. Braz. Genet. Mol. Res. 2012, 11:462-466.
5. Berumen J., Ordonez R.M., Lazcano E., Salmeron E., Galvan S.C., Estrada R.A., Yunes E., Garcia-Carranca A., Gonzalez-Lira G., Madrigal-de la Campa A. Asian-American variants of human papillomavirus 16 and risk for cervical cancer: a case-control study. J. Natl. Cancer Inst. 2001, 93:1325-1330.
6. Bernard H.U., Burk R.D., Chen Z., Van Doorslaer K., Hausen H., de Villiers E.M. Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology 2010, 401:70-79.
7. Bosch F.X., Lorincz A., Munoz N., Meijer C.J., Shah K.V. The causal relation between human papillomavirus and cervical cancer. J. Clin. Pathol. 2002, 55:244-265.
8. Schiffman M., Rodriguez A.C., Chen Z., Wacholder S., Herrero R., Hildesheim A., Desalle R., Befano B., Yu K., Safaeian M., Sherman M.E., Morales J., Guillen D., Alfaro M., Hutchinson M., Solomon D., Castle P.E., Burk R.D. A population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasia. Cancer Res. 2010, 70:3159-3169.
9. Cai H.B., Chen C.C., Ding X.H. Human papillomavirus type 16 E6 gene variations in Chinese population. Eur. J. Surg. Oncol. 2010, 36:160-163.
10. Calleja-Macias I.E., Villa L.L., Prado J.C., Kalantari M., Allan B., Williamson A.L., Chung L.P., Collins R.J., Zuna R.E., Dunn S.T., Chu T.Y., Cubie H.A., Cuschieri K., von Knebel-Doeberitz M., Martins C.R., Sanchez G.L., Bosch F.X., Munoz N., Bernard H.U. Worldwide genomic diversity of the high-risk human papillomavirus types 31, 35, 52 and 58, four close relatives of human papillomavirus type 16. J. Virol. 2005, 79:13630-13640.
11. Cento V., Rahmatalla N., Ciccozzi M., Perno C.F., Ciotti M. Intratype variations of HPV 31 and 58 in Italian women with abnormal cervical cytology. J. Med. Virol. 2011, 83:1752-1761.
12. Chagas B.S., Batista M.V.A., Guimarães V., Balbino V.Q., Crovella S., Freitas A.C. New variants of E6 and E7 oncogenes of human papillomavirus type 31 identified in northeastern Brazil. Gynecol. Oncol. 2011, 123:284-288.
13. Chen Z., Schiffman M., Herrero R., Desalle R., Anastos K., Segondy M., Sahasrabuddhe W., Gravitt P.E., Hsing A.W., Burk R.D. Evolution and taxonomic classification of human papillomavirus 16 (HPV16)-related variant genomes: HPV31, HPV33, HPV35, HPV52, HPV58 and HPV67. PLoS One 2011, 6:e20183.
14. Clifford G., Franceschi S., Diaz M., Munoz N., Villa L.L. Chapter 3: HPV type distribution in women with and without cervical neoplastic diseases. Vaccine 2006, 24:S26-S34.
15. de Villiers E.M., Frauquet C., Broker T.R., Bernard H.U., zur Hausen H. Classification of papillomaviruses. Virology 2004, 324:17-27.
16. Ellis J.R.M., Keating P.J., Baird J., Hounsell E.F., Renouf D.V., Rowe M., Hopkins D., Duggan-Keen M.F., Bartholomew J.S., Young L.S., et al. The association of an HPV 16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancer. Nat. Med. 1995, 1:464-470.
17. Ferenczy A., Franco E. Persistent human papillomavirus infection and cervical neoplasia. Lancet Oncol. 2002, 3:11-16.
18. Freitas A.C., Gurgel A.P.A.D., Chagas B.S., Coimbra E.C., Amaral C.M.M. Susceptibility to cervical cancer: an overview. Gynecol. Oncol. 2012, 126:304-311.
19. Garbuglia A.R., Carletti F., Minosse C., Piselli P., Zaniratti M.S., Serraino D., Capobianchi M.R. Genetic variability in E6 and E7 genes of human papillomavirus -16, -18, -31 and -33 from HIV-1-positive women in Italy. New Microbiol. 2007, 30:377-382.
20. Guindon S., Dufayard J.F., Lefort V., Anisimova M., Hordijk W., Gascuel O. New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0. Syst. Biol. 2010, 59:307-321.
21. Kammer C., Tommasino M., Syrjänen S., Delius H., Hebling U., Warthorst U., Pfister H., Zehbe I. Variants of the long control region and the E6 oncogene in European Human Papillomavirus type 16 isolates: implications for cervical disease. Br. J. Cancer 2002, 86:269-273.
22. Karlsen F., Kalantari M., Jenkins A., Pettersen E., Kristensen G., Holm R., Johansson E., Hagmar B. Use of multiple PCR primer sets for optimal detection of human papilomavírus. J. Clin. Microbiol. 1996, 34:2095-2100.
23. Kast W., Brandt R., Sidney J., Drijfhout J., Kubo R., Grey H., Melief C.J., Sette A. Role of HLA motifs in identification of potential CTL epitopes in human papillomavirus type 16 E6 and E7 proteins. J. Immunol. 1994, 152:3904-3912.
24. Lee K., Magalhaes I., Clavel C., Birembaut P., Tommasino M., Zehbe I. Distribution of human papillomavirus 16 E6, L1, L2 and E2 gene variants in pre-malignant cervical disease. Virus Res. 2008, 131:106-110.
25. Lichtig H., Algrisi M., Botzer L.E., Abadi T., Verbitzky Y., Jackman A., Tommasino M., Zehbe I., Sherman L. HPV16 E6 natural variants exhibit different activities in functional assays relevant to the carcinogenic potential of E6. Virology 2006, 350:216-227.
26. Londesborough P., Ho L., Terry G., Cuzick J., Wheeler C., Singer A. Human papillomavirus genotype as a predictor of persistence and development of high-grade lesions in women with minor cervical abnormalities. Int. J. Cancer 1996, 69:364-368.
27. Ma H., Hu Z., Zhai X., Wang S., Wang X., Qin J., Jin G., Liu J., Wang X., Wei Q., Shen H. Polymorphism in the MDM2 promoter and risk of breast cancer: a case-control analysis in a Chinese population. Cancer Lett. 2006, 240:261-267.
28. Manos M.M., Ting Y., Wright D.K., Lewis A.J., Broker T.R., Wolinsky S.M. The use of polymerase chain reaction amplification for the detection of genital human papillomavirus. Cancer Cells 1989, 7:209-214.
29. Matsumoto K., Yoshikawa H., Nakagawa S., Tang X., Yasugi T., Kawana K., Sekiya S., Hirai Y., Kukimoto I., Kanda T., Taketani Y. Enhanced oncogenecity of human papillomavirus type 16 (HPV16) variants in Japanese population. Cancer Lett. 2000, 156:159-165.
30. Posada D. JModelTest: phylogenetic model averaging. Mol. Biol. Evol. 2008, 25:1253-1256.
31. Prado J.C., Calleja-Macias I.E., Bernard H.U., Kalantari M., Macay S.A., Allan B., Williamson A.L., Chung L.P., Collins R.J., Zuna R.E., Dunn S.T., Ortiz-Lopez R., Barrera-Saldana H.A., Cubie H.A., Cuschieri K., von Knebel-Doeberitz M., Sanchez G.I., Bosch F.X., Villa L.L. Worldwide genomic diversity of the human papillomaviruses-53, 56 and 66, a group of high-risk HPVs unrelated to HPV-16 and HPV-18. Virology 2005, 340:95-104.
32. Richard C., Lanner C., Naryzhny S.N., Sherman L., Lee H., Lambert P.F., Zehbe I. The immortalizing and transforming ability of two common human papillomavirus 16 E6 variants with different prevalences in cervical cancer. Oncogene 2012, 29:3435-3445.
33. Saha S., Raghava G.P. BcePred: Prediction of continuous B-Cell epitopes in antigenic sequences using physico-chemical properties. ICARIS 2004, LNCS 3239 2004, 197-204. Springer. G. Nicosia, V. Cutello, P.J. Bentley, J. Timis (Eds.).
34. Schiffman M.H., Bauer H.M., Hoover R.N., Glass A.G., Cadell D.M., Rush B.B., Scott D.R., Sherman M.E., Kurman R.J., Wacholder S., et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J. Natl. Cancer Inst. 1993, 85:958-964.
35. Schiffman M., Rodriguez A.C., Chen Z., Wacholder S., Herrero R., Hildesheim A., Desalle R., Befano B., Yu K., Safaeian M., Sherman M.E., Morales J., Guillen D., Alfaro M., Hutchinson M., Solomon D., Castle P.E., Sichero L., Villa L.L. Epidemiological and functional implications of molecular variants of human papillomavirus. Braz. J. Med. Biol. Res. 2006, 39:707-717.
36. Sichero L., Ferreira S., Trottier H., Duarte-Franco E., Ferenczy A., Franco E.L., Villa L.L. High grade cervical lesions are caused preferentially by non-European variants of HPVs 16 and 18. Int. J. Cancer 2007, 120:1763-1768.
37. Sichero L., Sobrinho J.S., Villa L.L. Oncogenic potential diverge amomg human papillomavitus type 16 natural variants. Virology 2012, 432:127-132.
38. Singh H., Raghava G.P. ProPred: prediction of HLA-DR binding sites. Bioinformatics 2001, 17:1236-1237.
39. Singh H., Raghava G.P. ProPred1: prediction of promiscuous MHC Class-I binding sites. Bioinformatics 2003, 22:1009-1014.
40. Staden R. The staden sequence analysis package. Mol. Biotechnol. 1996, 5:233-241.
41. Thompson J.D., Higgins D.G., Gibson T.J. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignments through sequence weighting, position specific gap penalties and weight matrix choice. Nucleic Acids Res. 1994, 22:4673-4680.
42. Xi L.F., Demers G.W., Koutsky L.A., Kiviat N.B., Kuypers J., Watts D.H., Holmes K.K., Galloway D.A. Analysis of human papillomavirus type 16 variants indicates establishment of persistent infection. J. Infect. Dis. 1995, 172:747-755.
43. Xi L.F., Koutsky L.A., Hildesheim A., Galloway D.A., Wheeler C.M., Winer R.L. Risk for high-grade cervical intraepithelial neoplasia associated with variants of human papillomavirus types 16 and 18. Cancer Epidemiol. Biomarkers Prev. 2007, 16:4-10.
44. Xi L.F., Schiffman M., Koutsky L.A., Hulbert A., Lee S.K., Defilippis V., Shen Z., Kiviat N.B. Association of human papillomavirus type 31 variants with risk of cervical intraepithelial neoplasia grade 2-3. Int. J. Cancer 2012, 131:2300-2307.
45. Zehbe I., Voglino G., Delius H., Wilander E., Tommasino M. Risk of cervical Cancer and geographical variations of human papillomavirus 16 E6 polymorphisms. Lancet 1998, 352:1441-1442.
46. Zehbe I., Voglino G., Wilander E., Delius H., Marongiu A., Edler L., Klimek F., Andersson S., Tommasino M. P53 codon 72 polymorphism and various human papillomavirus 16 E6 genotypes are risk factors for cervical cancer development. Cancer Res. 2001, 61:608-611.
47. Zehbe I., Mytilineos J., Wikstrom I., Henriksen R., Edler L., Tommasino M. Association between human papillomavirus 16 E6 variants and human leukocyte antigen class I polymorphism in cervical cancer of Swedish women. Hum. Immunol. 2003, 64:538-542.
48. Zehbe I., Lichtig H., Westerback A., Lambert P.F., Tommasino M., Sherman L. Rare human papillomavirus 16 E6 variants reveal significant oncogenic potential. Mol. Cancer 2011, 10:77.
49. Walboomers J.M.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V., Snijders P.J., Peto J., Meijer C.J., Munoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 1999, 189:12-19.